PDS Biotechnology's market cap is currently $47.61M. The company's EPS TTM is $-0.19; its P/E ratio is -1.06; PDS Biotechnology is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
